Market Closed

MCRB
Seres Therapeutics
$ 1.40
-0.71%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Seres Therapeutics News

Latest Seres Therapeutics Stock News & MCRB Headlines

Seres Therapeutics (MCRB) Reports Q3 Loss, Beats Revenue Estimates
12 days ago | zacks.com
Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below Fifty Day Moving Average – Here’s Why
a month ago | defenseworld.net
Seres Therapeutics (NASDAQ:MCRB) Share Price Breaks Below 50 Day Moving Average – Should You Sell?
2 months ago | defenseworld.net
Seres Therapeutics (NASDAQ:MCRB) and Celldex Therapeutics (NASDAQ:CLDX) Head to Head Review
2 months ago | defenseworld.net
Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs
3 months ago | globenewswire.com
Seres Therapeutics Posts Early Data for Cancer Therapy Complication
4 months ago | benzinga.com
Seres Therapeutics, Inc. (MCRB) Discusses Promising SER-155 Clinical Trial Results for Immune Checkpoint Inhibitor Related Andropilatis Transcript
4 months ago | seekingalpha.com
Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027
5 months ago | globenewswire.com
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
6 months ago | globenewswire.com
Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
6 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

MCRB
Seres Therapeutics
$ 1.40
-0.71%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago